Setting up Multiplex Panels for Genetic Testing of Familial Hypertrophic Cardiomyopathy Based on Linkage Analysis

Area of Science:

• Genetics
• Cardiology
• Molecular Biology

Background:

• Familial hypertrophic cardiomyopathy (HCM) is a genetic heart condition caused by mutations in cardiac sarcomere proteins.
• Genetic testing is crucial for HCM diagnosis, prognosis, and screening high-risk individuals.
• Developing population-specific genetic testing strategies is essential for clinical application.

Purpose of the Study:

• To develop and validate a reliable genetic testing strategy for familial HCM.
• To adapt linkage analysis for the Iranian population.
• To assess the utility of six key sarcomere genes in HCM diagnosis.

Main Methods:

• Selected six panels of four microsatellite markers each, targeting MYH7, MYBPC3, TNNT2, TNNI3, TPM1, and MYL2 genes.
• Utilized multiplex PCR and fragment length analysis for marker evaluation in 50 unrelated Iranians.
• Verified the strategy's efficacy in an Iranian family affected by HCM.

Main Results:

• All selected microsatellite markers demonstrated high polymorphism.
• The marker panels proved informative in 96-100% of tested samples.
• Multipoint linkage analysis excluded linkage between familial HCM and the six evaluated sarcomere genes (maximum LOD score ≤-2).

Conclusions:

• A reliable genetic testing strategy for familial HCM based on linkage analysis of six sarcomere genes was established.
• This method is suitable for diagnostic, predictive, and screening applications in clinical settings.
• The study provides a valuable tool for genetic assessment of HCM in the Iranian population.